As of October 28, 2026, GeoVax Labs, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on October 27, 2026 (Form 8-K, October 27, 2026).
Sell to companies like GeoVax Labs, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
GeoVax Labs, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-10-27. Every row below is cited to the filing it comes from, and this page adds each new change as GeoVax Labs, Inc. files it.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-27 | Reported | not named in the filing | 8-K, 2026-10-27 |
Selling to them or working with them? See who runs GeoVax Labs, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on GeoVax Labs, Inc. and the records around it.
GeoVax Labs, Inc. elsewhere on the record
Companies that share a holder
- Ayrton Capital LLC also filed stake reports on 31 other companies: Bluejay Diagnostics, Inc. (Aug 2026), BTC Digital Ltd. (Aug 2026), CHINA NATURAL RESOURCES INC (Aug 2026)
- L1 Capital Global Opportunities Master Fund, Ltd. also filed stake reports on 41 other companies: INLIF Ltd (Oct 2026), DarkIris Inc. (Oct 2026), Baird Medical Investment Holdings Ltd (Oct 2026)
- Mitchell P. Kopin also filed stake reports on 55 other companies: SCWorx Corp. (Sep 2026), NFT Limited (Aug 2026), Silexion Therapeutics Corp (Aug 2026)
Watch GeoVax Labs, Inc.
Get an email when GeoVax Labs, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on GeoVax Labs, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on GeoVax Labs, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on GeoVax Labs, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
New leaders reset buying decisions — get the Full Report on GeoVax Labs, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at GeoVax Labs, Inc., with the record behind each one.
Find candidates like senior executive at GeoVax Labs, Inc.Every change, in the filing's words
Reported
Effective October 23, 2026, five of the Company's directors, Randal Chase, Dean Kollintzas, Nicole Lemerond, Jayne Morgan and John Spencer, Jr., resigned from the Company's Board of Directors, and the remaining members of the Company's Board of Directors (the "Remaining Directors") appointed three individuals designated by the Lender, Steven Brown, Tyler O'Brien and Manpreet Uppal as directors (the "Lender Board Nominees").
Tools for this story
Each opens in a new tab, filled in for GeoVax Labs, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.